loader2
Partner With Us NRI

Shilpa Medicare Ltd share Price Today

Company details

525.10
560.00
235.50
561.60
6M Return 40.83%
1Y Return 122.94%
Mkt Cap.(Cr) 5,212.75
Volume 189,304
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 189,304

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Shilpa Medicare Ltd shares SWOT Analysis

Strengths (9)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Strong Annual EPS Growth
  • Growth in Net Profit with increasing Profit Margin (QoQ)

Weakness (2)

  • Promoter holding decreased by more than -2% QoQ
  • Companies with High Promoter Pledge

Opportunity (2)

  • Highest Recovery from 52 Week Low
  • RSI indicating price strength

Threats (3)

  • Promoter decreasing their shareholding
  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 553.7
R2 574.3
R3 588.6
Pivot

539.38

S1 518.8
S2 504.5
S3 483.9
EMA SMA
514.7
499.1
467.2
422.6
504.1
513.6
458.8
406.2
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
PLUTUS WEALTH MANAGEMENT LLP Bulk Purchase 2024-06-05 492.34 750000 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2024-02-21 443.95 482523 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Sell 2024-02-21 444.09 482523 NSE
Name Category Shares
VISHNUKANT CHATURBHUJ BHUTADA PROMOTER 6.51%
DHARMAVATI BHUTADA PROMOTER 6.35%
RAVI KUMAR INNANI PROMOTER 4.1%
SURAJ KUMAR INNANI PROMOTER 4.07%
OM PRAKASH INANI PROMOTER 2.93%
DEEPAK KUMAR INNANI PROMOTER 2.8%
KANTADEVI INANI PROMOTER 2.6%
KESHAV BHUTADA PROMOTER 2.05%
MADHAV VISHNUKANT BHUTADA PROMOTER 2.05%
RAMAKANT INNANI PROMOTER 1.53%
VISHNUKANTH C BHUTADA PROMOTER 1.37%
TARADEVI INNANI PROMOTER 1.28%
VISHNUKANTA INANI PROMOTER 1.24%
BRIJGOPAL INNANI PROMOTER 1.2%
NATAMAL INNANI PROMOTER 1.16%
SHAKUNTALABAI INNANI PROMOTER 1.15%
SAGAR INNANI PROMOTER 1.02%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Shilpa Medicare Ltd Stocks COMPARISON

Financials( in Cr) Shilpa Medicare Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 533.05 1,516.00 1,564.75 4,588.60 1,109.55
% Change -2.53 0.34 1.31 -0.11 1.75
Mcap Cr 5,212.75 363,739.19 126,332.75 121,813.11 111,646.69
Revenue TTM Cr 1,050.11 43,885.68 15,790.60 7,767.51 17,237.40
Net Profit TTM Cr -30.92 8,560.84 2,513.47 1,823.38 1,997.30
PE TTM 168.48 36.34 29.68 76.10 28.94
1 Year Return 122.94 53.43 59.42 31.57 114.34
ROCE -0.84 16.79 14.76 19.30 16.25
ROE 3.49 16.46 10.66 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 1,783.28 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 32,317.57 -2,589.17
LAST 3M 111,725.82 -36,230.77
LAST 6M 182,653.52 -16,910.03
LAST 12M 290,144.87 98,834.05

Shilpa Medicare Ltd Information

Stock PE (TTM)
168.48
Promoter Holding
44.39%
Book Value
236.0843
ROCE
-0.84%
ROE
3.49%
Description
  • Shilpa Medicare, founded in 1989, is a producer and marketer of pharmaceutical products. The company has a special focus on oncology. It also conducts research and development of drugs and drug formulations and is taking steps towards developing novel drug delivery systems and biotech products. Shilpa Medicare has branch offices and production units across India and its corporate office in Raichur, Karnataka. 

    On 13 February 2023, the market capitalisation of the company was Rs 2,083.68 crore. It reported consolidated sales of Rs 68.7 crore at the end of September 2022. The company is listed on the Bombay Stock Exchange with the code 530549 and the National Stock Exchange with the code SHILPAMED.

    On 31 December 2022, the company’s shareholding pattern indicated a promoter stake of 50.01%. The foreign institutional investor stake in the company was 15.32%. Domestic mutual funds and other domestic institutional investors held a stake of 0.61%. Retail investors and others held a stake of 34.06% in the company. The shareholding pattern has remained largely consistent over the past year. 

    The company’s board of directors comprises Omprakash Inani, Vishnukant Chaturbhuj Bhutada, Sharath Reddy Kalakota, Anita Bandyopadhyay, Arvind Vasudeva, Hetal Madhukant Gandhi, Kamal K Sharma, Sirisha Chintapalli, and others. The auditors are Bohara Bhandari Bung & Associates LLP and Brahmayya & Co. On 30 September 2022, the company had a total of 8.68 crore shares outstanding.

    On 13 February 2023, Shilpa Medicare’s share price on BSE was Rs 241.10 and Rs 241.60 on NSE. The share price touched a 52-week high of Rs 509.00 and a 52-week low of Rs 231.80. Its three-month return to investors was -19.08%, while its one-year return was -50.19%.

    On November 2022, Nippon India Nifty Smallcap 250 Index Fund Direct-Growth had invested Rs 0.48 crore in the company while Motilal Oswal Nifty Smallcap 250 Index Fund Direct-Growth and SBI Nifty Smallcap 250 Index Fund Direct-Growth had invested Rs 0.39 crore and Rs 0.18 crore, respectively.

    On November 2022, the company had a trailing-twelve-month (TTM) revenue of Rs 1,145.52 crore. The company also had a net profit of Rs 60.58 crore during the same period.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code: 07730), BSE Ltd (Member Code: 103) and Member of Multi Commodity Exchange of India Ltd.(Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

Registered Address

#12-6-214/A1, Hyderabad Road, Raichur, Karnataka, 584135

Tel : 91-8532-238704
Email : info:vbshilpa.com
Website : http://www.vbshilpa.com
Registrar

KFin Techologies Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 530549
NSE Code : SHILPAMED
Book Closure Date (Month) : Sep
BSE Group : A
ISIN : INE790G01031

FAQ’s on Shilpa Medicare Ltd Shares

You can buy Shilpa Medicare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Shilpa Medicare Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 14, 2024 03:53 PM the closing price of Shilpa Medicare Ltd was Rs.533.05.

The latest PE ratio of Shilpa Medicare Ltd as of Jun 14, 2024 03:53 PM is 168.48

The latest PB ratio of Shilpa Medicare Ltd as of Jun 14, 2024 03:53 PM is 0.44

The 52-week high of Shilpa Medicare Ltd share price is Rs. 561.60 while the 52-week low is Rs. 235.50

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 14, 2024 03:53 PM, the market cap of Shilpa Medicare Ltd stood at Rs. 5,212.75.

Download App

Download Our App

Play Store App Store
market app